Last edition
News about "human monoclonal antibody "
Novartis' Ianalumab Receives FDA Breakthrough Therapy Designation for Sjogren's Disease
The FDA has granted Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s disease, accelerating its review as a potential first targeted treatment, with global filings planned from 2026.
Human Monoclonal Antibody | 19/01/2026 | By News Bureau | 180
AbbVie and FutureGen to Develop Next-Gen Therapy for Inflammatory Bowel Disease
AbbVie has signed a license agreement with FutureGen Biopharmaceutical to develop FG-M701, a next-generation TL1A antibody for the treatment of IBD currently in preclinical development.
Human Monoclonal Antibody | 14/06/2024 | By Aishwarya | 462
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy